bpc 157 cycle forum What to Know About Peptides the FDA Is Considering for Use The Human Lab Rats Injecting

Be aware that medications from a compounding pharmacy may more or less concentrated than FDA-approved drugs

[9] Healthcare providers and laboratory personnel should be aware the patient is on sermorelin, so that lab results are interpreted appropriately

Concentration equals mass divided by diluent volume

A comparative study of the BPC 157 beneficial effect was done with intraperitoneal application, once daily, intraperitoneally (per kg body weight) 10 g, 10 ng, or 10 pg BPC 157, while standard agents 10 mg atropine, 50 mg ranitidine, and 50 mg omeprazole provide only a weak effect

This is about much more than peptides